Drug Shortage Report for MESNA FOR INJECTION
Report ID | 201038 |
Drug Identification Number | 02244931 |
Brand name | MESNA FOR INJECTION |
Common or Proper name | MESNA FOR INJECTION |
Company Name | FRESENIUS KABI CANADA LTD |
Market Status | MARKETED |
Active Ingredient(s) | MESNA |
Strength(s) | 100MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAVENOUS INTRAVENOUS |
Packaging size | 10mL |
ATC code | V03AF |
ATC description | ALL OTHER THERAPEUTIC PRODUCTS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2023-06-30 |
Estimated end date | Unknown |
Actual end date | |
Shortage status | Actual shortage |
Updated date | 2024-01-09 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 165 GALAXY BLVD, SUITE 100 TORONTO, ONTARIO CANADA M9W 0C8 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v10 | 2024-01-09 | French | Compare |
v9 | 2024-01-09 | English | Compare |
v8 | 2023-11-29 | French | Compare |
v7 | 2023-11-29 | English | Compare |
v6 | 2023-11-29 | French | Compare |
v5 | 2023-11-29 | English | Compare |
v4 | 2023-09-18 | French | Compare |
v3 | 2023-09-18 | English | Compare |
v2 | 2023-08-03 | French | Compare |
v1 | 2023-08-03 | English | Compare |
Showing 1 to 10 of 10